ASML: UBS still on hold

(CercleFinance.com) - UBS reiterates its Neutral rating on the stock, leaving its target price unchanged at E740.
This TP represents 16% upside potential for the stock.

ASML's 2024 report highlights steady growth in services in China and continued investment in R&D, reinforcing its strong market position and commitment to innovation, UBS says.

The Dutch group is targeting sales of E7.5bn to E8bn and a gross margin of 52% to 53% for Q1 2025, as well as target ranges of 30-35 and 51-53% respectively for the full year.


Copyright (c) 2025 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as decision-making aids for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.